Human notochordal cell transcriptome unveils potential regulators of cell function in the developing intervertebral...

Area of Science:

• Developmental Biology
• Molecular Biology
• Regenerative Medicine

Background:

• Adult nucleus pulposus cells derive from the embryonic notochord.
• Loss of notochordal cells contributes to human intervertebral disc degeneration.
• Understanding notochordal cell phenotype is vital for developing therapies.

Purpose of the Study:

• To perform detailed transcriptomic profiling of human embryonic and fetal notochordal cells.
• To identify notochord-specific markers and key regulatory pathways.
• To explore therapeutic targets for intervertebral disc degeneration.

Main Methods:

• Isolation of notochordal cells from human embryonic/fetal spines (7.5-14 weeks) using Fluorescence-Activated Cell Sorting (FACS) with CD24 marker.
• Transcriptomic analysis via microarray and quantitative PCR (qPCR) validation.
• Ingenuity pathway analysis to identify master regulators.

Main Results:

• Identified CD24, STMN2, RTN1, PRPH, CXCL12, IGF1, MAP1B, ISL1, CLDN1, and THBS2 as notochord-specific markers.
• Confirmed expression of these markers in aged and degenerate disc nucleus pulposus cells.
• Revealed WISP2, Noggin, EDN2 (anti-vascularization) and IL1-RN (anti-inflammation) as master regulators.

Conclusions:

• First definition of the human notochordal cell transcriptome.
• Notochordal cells may inhibit vascularization and inflammation during disc development.
• Identified molecules and pathways offer potential for preventing/treating disc degeneration.